Senti Biosciences Inc (SNTI) — Strategic Asset Allocation Index
Senti Biosciences Inc (SNTI) has a Strategic Asset Allocation Index of 60.5% as of June 2023. Strategic assets (PP&E of $58.94 Million plus long-term investments of $-) total $58.94 Million, measured against net assets of $97.42 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Senti Biosciences Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Senti Biosciences Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Senti Biosciences Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2022. As of June 2023, the index stands at 60.5%, representing strategic assets of $58.94 Million against net assets of $97.42 Million USD. For live market cap and overall valuation, see Senti Biosciences Inc (SNTI) total market value.
Annual Strategic Asset Allocation Index for Senti Biosciences Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Senti Biosciences Inc from 2019 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Senti Biosciences Inc (SNTI) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44.1% | $56.14 Million | $56.14 Million | $- | $127.26 Million | ▼ -10.7 pp |
| 2021 | 54.8% | $33.08 Million | $33.08 Million | $- | $60.38 Million | ▼ -37.5 pp |
| 2019 | 92.3% | $16.59 Million | $16.59 Million | $- | $17.96 Million | — |